Loading
Fetching the latest research
Eyting M, Xie M, Michalik F, Heß S, Chung S, Geldsetzer P.
Paper source
A natural experiment on the effect of herpes zoster vaccination on dementia.
This rigor review was examined and confirmed by Αlpha¹ Editorial · July 5, 2026
Αlpha¹ assesses methodological rigor, not the importance of the findings. See how we calibrate →
This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.
The paper is methodologically strong, leveraging a well-justified regression discontinuity design with careful balance tests, sensitivity analyses, and independent replication. The main rigor gaps are the absence of a power analysis, missing outlier-handling description, and an incomplete ethics statement (informed consent/waiver not mentioned). A minor reporting concern is an overstated projection about cost-effectiveness not supported by data in the paper.
Three independent rigor evaluations were synthesized. The reviewers agreed on 6 of 8 dimensions; for study design and ethical approvals, the 'warn' was upheld by weighing specific evidence from the dissenting reviewers. Statistics verification covered 4 tests (all consistent); the coverage note warns that not all results were machine-checked. Key resources was the most divergent dimension (pass, warn, N/A) — the final 'pass' reflects that the vaccine is adequately identified for a non-interventional study and software is shared. The paper was evaluated as a published article (post-publication audit mode).
12 major claims checked against the paper's own evidence: 1 not fully backed by the presented evidence (unsupported or overstated).
Recomputed 4 tests: 4 consistent, 0 inconsistent, 4 via agent-written checks.
3 copyedit issues flagged: mostly other, clarity, consistency.
2 data/code links checked; 2 live.
Registration stated in text, but no registry ID was detected. No reporting guideline cited.
The published work is methodologically robust and the core finding (zoster vaccine reduces dementia diagnoses) is supported by careful quasi-experimental evidence. An informed reader should note the absence of a power analysis (the sample is fixed, but a justification for the detectable effect size would strengthen null-interpretation), and the missing informed-consent waiver statement is a reporting gap rather than an ethical violation. The overstated cost-effectiveness claim in the discussion warrants tempering or removal. These issues would justify an erratum or author correction, not a full replication, but do not undermine the primary conclusion.